These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34530804)

  • 1. Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases.
    Azarpanah H; Farhadloo M; Vahidov R; Pilote L
    BMC Public Health; 2021 Sep; 21(1):1686. PubMed ID: 34530804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL; Arana J; Marquez PL; Ng C; Barash F; Hibbs BF; Cano M
    Vaccine; 2019 Jun; 37(28):3730-3734. PubMed ID: 31155414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Moro PL; Zheteyeva Y; Barash F; Lewis P; Cano M
    Vaccine; 2018 Jan; 36(1):50-54. PubMed ID: 29174107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
    Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.
    Haber P; Moro PL; Ng C; Dores GM; Perez-Vilar S; Marquez PL; Cano M
    Vaccine; 2020 Feb; 38(6):1476-1480. PubMed ID: 31883809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Clinical Decision Support for Vaccine Adverse Event Detection and Reporting.
    Baker MA; Kaelber DC; Bar-Shain DS; Moro PL; Zambarano B; Mazza M; Garcia C; Henry A; Platt R; Klompas M
    Clin Infect Dis; 2015 Sep; 61(6):864-70. PubMed ID: 26060294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust?
    Scherer LD; Shaffer VA; Patel N; Zikmund-Fisher BJ
    Vaccine; 2016 May; 34(21):2424-2429. PubMed ID: 27049120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021.
    Day B; Menschik D; Thompson D; Jankosky C; Su J; Moro P; Zinderman C; Welsh K; Dimova RB; Nair N
    Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):763-772. PubMed ID: 36813704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.
    Miller ER; Moro PL; Cano M; Lewis P; Bryant-Genevier M; Shimabukuro TT
    Vaccine; 2016 May; 34(25):2841-6. PubMed ID: 27087150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States.
    Sonawane K; Lin YY; Damgacioglu H; Zhu Y; Fernandez ME; Montealegre JR; Cazaban CG; Li R; Lairson DR; Lin Y; Giuliano AR; Deshmukh AA
    JAMA Netw Open; 2021 Sep; 4(9):e2124502. PubMed ID: 34533574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.
    Hibbs BF; Moro PL; Lewis P; Miller ER; Shimabukuro TT
    Vaccine; 2015 Jun; 33(28):3171-8. PubMed ID: 25980429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
    Varricchio F; Iskander J; Destefano F; Ball R; Pless R; Braun MM; Chen RT
    Pediatr Infect Dis J; 2004 Apr; 23(4):287-94. PubMed ID: 15071280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Haber P; Moro PL; Ng C; Dores GM; Lewis P; Cano M
    Vaccine; 2019 Mar; 37(11):1516-1520. PubMed ID: 30739795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
    Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cognitive biases with human papillomavirus vaccine hesitancy: a cross-sectional study.
    Pomares TD; Buttenheim AM; Amin AB; Joyce CM; Porter RM; Bednarczyk RA; Omer SB
    Hum Vaccin Immunother; 2020 May; 16(5):1018-1023. PubMed ID: 31859593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
    Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.